HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir AB (OMX: MVIR), a research-based pharmaceutical company focused on infectious diseases, announced today that it has initiated a collaboration with researchers at the Swedish University of Agricultural Sciences aimed at identifying and developing new drugs against bacteria that have become resistant to current antibiotics. The researchers at the Swedish University of Agricultural Sciences (SLU) have extensive experience of isolating new microorganisms and their metabolites (intermediates and products of metabolism) with which microorganisms compete with each other in nature. These low molecular-weight chemical compounds with potentially novel mechanisms of action may serve as the starting point for developing new antibiotics to treat severe bacterial infections.
